Cargando…

Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19

Detalles Bibliográficos
Autores principales:	Chen, Jiezhong, Vitetta, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482650/ https://www.ncbi.nlm.nih.gov/pubmed/34601117 http://dx.doi.org/10.1016/j.clim.2021.108870

Ejemplares similares

Gut-brain axis in the neurological comorbidity of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions
por: Vitetta, Luis, et al.
Publicado: (2023)

Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2022)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

Strengthening Communities’ Youth Access Policies May Facilitate Clean Indoor Air Action
por: Jason, Leonard A, et al.
Publicado: (2007)

The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
por: Chen, Jiezhong, et al.
Publicado: (2021)

Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences
por: Vitetta, Luis, et al.
Publicado: (2015)

Increasing Resistance in Commensal Escherichia coli, Bolivia and Peru
por: Bartoloni, Alessandro, et al.
Publicado: (2008)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
por: Finsterer, Josef
Publicado: (2021)

Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
por: Mantero, Vittorio, et al.
Publicado: (2020)

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
por: Michot, J.-M., et al.
Publicado: (2020)

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted
por: Panda, Aditya K., et al.
Publicado: (2021)

IL-6 may be a good biomarker for earlier detection of COVID-19 progression
por: Wang, Changsong, et al.
Publicado: (2020)

Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
por: Chen, Jiezhong, et al.
Publicado: (2019)

IL-6 Variants in Ischemic Stroke
por: Sand, Philipp G.
Publicado: (2016)

Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
por: Guo, Yukuang, et al.
Publicado: (2020)

IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
por: Giannitrapani, Lydia, et al.
Publicado: (2022)

In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia
por: Kim, Si-Ho, et al.
Publicado: (2022)

Strengthening early testing and surveillance of COVID-19 to enhance identification of asymptomatic patients
por: Wong, Martin CS, et al.
Publicado: (2020)

GIS for Dengue Surveillance: Strengthening Collaborations
por: Hsu, Chien-Yeh, et al.
Publicado: (2012)

Gut commensals and their metabolites in health and disease
por: Krishnamurthy, Hari Krishnan, et al.
Publicado: (2023)

Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
por: Chen, Jiezhong, et al.
Publicado: (2022)

COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries
por: Khan, Zakir, et al.
Publicado: (2022)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Preserve and strengthen family to promote mental health
por: Raj, Rajnish
Publicado: (2010)

Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?
por: Ch’ng, Ewe Seng, et al.
Publicado: (2020)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections
por: Mustafa, Mohd Zulkifli, et al.
Publicado: (2020)

Duplicate publication and the need to strengthen editorial policy of the journal
por: Das, Natasha
Publicado: (2017)

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”
por: Kobak, Senol
Publicado: (2020)

Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10
por: Liu, X S
Publicado: (2010)

May We Strengthen the Human Natural Defenses with Bacterial Lysates?
por: Villa, Elisa, et al.
Publicado: (2010)

COVID-19 and primary care: A critical need for strengthening emergency preparedness across health systems
por: Sultana, Abida, et al.
Publicado: (2021)

May polyenthesitis follow COVID-19?
por: Ciaffi, Jacopo, et al.
Publicado: (2021)

Comment on Carson et al: Strengthening global health security – lessons learned from Public Health England’s International Health Regulations strengthening project
por: Razavi, Ahmed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gkb4oet4q6i43clfhhql7sku8